Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.89
+0.45 (+0.36%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
69
70
Next >
Could This Opportunity Make Moderna a Hot Buy Again?
December 21, 2022
Merck and Moderna recently announced positive results from a trial involving their personalized cancer vaccine.
Via
The Motley Fool
Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings
December 21, 2022
Via
Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
Although Gilead Sciences produced meaningful results regarding a lung cancer drug test, the competitive shortfall hurt GILD stock.
Via
InvestorPlace
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
December 20, 2022
Via
Benzinga
Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche
December 20, 2022
Gilead and Arcus toppled Tuesday after their lung-cancer regimen trailed a rival concoction from Roche.
Via
Investor's Business Daily
Why Moderna Stock Is Popping Over 20% Today
December 13, 2022
Moderna Stock is ripping higher today after a cancer treatment breakthrough. Is Moderna stock a buy now?
Via
The Motley Fool
2 Smartest Tech Stocks to Buy in 2022 and Beyond
December 20, 2022
The tech space is still bursting with opportunities for long-term investors.
Via
The Motley Fool
Tuesday Talk: Where is Santa?
December 20, 2022
Monday continued the downtrend for the major indices on Wall Street which concluded a second week of losses on Friday. As for an annual Santa rally, that seems nowhere to be found.
Via
Talk Markets
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro
December 19, 2022
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning.
Via
Talk Markets
What's Going On With Moderna Stock Monday?
December 19, 2022
Moderna Inc (NASDAQ: MRNA) shares are trading higher Monday following positive analyst coverage from Jefferies.
Via
Benzinga
Are These Multibillion-Dollar Vaccine Stocks Still a Buy?
December 18, 2022
Moderna and Merck are up on the news regarding their melanoma cancer vaccine.
Via
The Motley Fool
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
December 16, 2022
Moderna spiked on a cancer vaccine while Tesla continued to dive.
Via
Investor's Business Daily
2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
December 16, 2022
Two drug developers stand out as plain-as-day bargains in the new year, while another top-performing biotech stock looks poised to disappoint.
Via
The Motley Fool
20 Dividend Growth Stocks For Faster Growth And Profit
December 15, 2022
The equal weight growth model was willing to accept faster-growing companies with lower current dividend yields, but faster-growing dividends.
Via
Talk Markets
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
December 15, 2022
Via
Benzinga
Elon Musk Dumps Another $3.6B Tesla Stock, Facebook's Jobs' Feature To Disappear Next Year, Foxconn Relaxes Covid Restrictions In China Factory: Today's Top Stories
December 15, 2022
Benzinga Elon Musk Dumps Another $3.6 Billion Of Tesla Stock
Via
Benzinga
2 Dividend Stocks to Buy and Hold Through 2023 and Beyond
December 15, 2022
These pharma giants are crushing the broader market this year.
Via
The Motley Fool
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies
December 15, 2022
Via
Benzinga
The Best ETF For Dividend Yield And Dividend Growth
December 15, 2022
This ETF checks off all the boxes in terms of performance, dividend growth, and solid yield.
Via
The Motley Fool
FDA Extends Review Period For AstraZeneca-Merck Partnered Cancer Drug, Lynparza
December 15, 2022
Via
Benzinga
Is Moderna a Good Stock to Buy Right Now?
December 15, 2022
Recent results suggest the company's cancer vaccine candidate can succeed where others have failed.
Via
The Motley Fool
Finding 20 Dividend Growth Stocks In A Bad Market
December 14, 2022
Starting in 2012, it became more and more difficult for prudent dividend growth stock investors looking for income. The stock market was trading at excessive valuations, and interest rates were at...
Via
Talk Markets
Moderna Stock Shows Surprising Strength; Key Rating Upgraded
December 14, 2022
See if Moderna stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day average.
Via
Investor's Business Daily
7 Stocks to Buy on the Dip as the S&P 500 Falters
December 14, 2022
Investors looking for a margin of safety and growth even in a recession should consider these cheap stocks to buy on the dip.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Is Moderna Stock a Buy After Its Impressive Cancer Vaccine Results?
December 14, 2022
Moderna could have a winner with its personalized cancer vaccine. But the company also faces big questions.
Via
The Motley Fool
Market Volatility Drops Sharply Ahead Of Fed's Rate Decision
December 14, 2022
US stocks closed higher on Tuesday, after the recent data showed the smallest annual rise in inflation in around one year. The consumer price index rose 0.1% in November following a 0.4% increase in...
Via
Benzinga
Tesla, Amazon, Coinbase, Moderna, Nuwellis: Why These 5 Stocks Are Drawing Investors' Attention Today
December 13, 2022
Major Wall Street indices closed in the green on Tuesday after consumer price inflation at 7.1% for November came in lower than expected.
Via
Benzinga
Moderna Soars On Cancer Vaccine News: Here's What To Watch Going Forward
December 13, 2022
Moderna, Inc (NASDAQ: MRNA) gapped up 13% to start the trading day on Tuesday and was skyrocketing an additional 12% intraday after announcing that its Merck & Co, Inc (NYSE: MRK) partnered cancer
Via
Benzinga
The 7 Best Investment Funds to Navigate a Possible Recession
December 13, 2022
With a possible recession on the horizon, investors may be able to protect themselves through the best investment funds.
Via
InvestorPlace
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.